Evidence map›Paper›PMID 41127819›Full record

ArticleComputational and structural biotechnology journal2025

Influence of PARP1 on CRISPR/Cas9 induced double strand break repair in proliferating cells.

Tobias Wimmer, Judith Schneider, Fatimah Alabudeeb, Franziska M Türk, Lyubomyr Lytvynchuk, Knut Stieger

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tobias WimmerDepartment of Ophthalmology, Justus-Liebig-University Giessen, Germany.
Judith SchneiderDepartment of Ophthalmology, Justus-Liebig-University Giessen, Germany.
Fatimah AlabudeebDepartment of Ophthalmology, Justus-Liebig-University Giessen, Germany.
Franziska M TürkDepartment of Ophthalmology, Justus-Liebig-University Giessen, Germany.
Lyubomyr LytvynchukDepartment of Ophthalmology, Justus-Liebig-University Giessen, Germany.
Knut StiegerDepartment of Ophthalmology, Justus-Liebig-University Giessen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome editing with CRISPR/Cas9 depends on the induction of site-specific DNA double-strand breaks (DSBs), which are repaired by distinct pathways. Non-homologous end joining (NHEJ) frequently introduces insertions or deletions (indels), resulting in mutagenic repair, whereas microhomology-mediated end joining (MMEJ) produces larger deletions due to end resection. In the presence of a donor template, homologous recombination (HR) enables precise sequence changes but is generally inefficient in many cell types. Modulating the activity of key repair factors has therefore emerged as a promising strategy to bias DSB repair outcomes toward more predictable or precise edits. Here, we employed luminescent and fluorescent reporter assays to systematically quantify the impact of PARP1 modulation on repair pathway choice. We show that PARP1 downregulation increased both NHEJ and MMEJ repair without altering HR, while PARP1 overexpression reduced NHEJ and HR but left MMEJ activity unaffected. These results highlight PARP1 as a regulator of DSB repair balance and suggest that targeted modulation of PARP1 could improve the precision of CRISPR-based genome editing.

Indexed as

Cellular Reporter AssayCRISPR/Cas9DNA RepairPARP1

Identifiers

PMID41127819
PMCPMC12538023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.